ABSTRACT To establish whether dehydroepiandrosterone (DHEA) as a neurosteroid could enhance the rate of neuronal differentiation in neuronal-competent bone marrow mesenchymal stem cells (BM-MSCs), we added DHEA before and after plating the neurosphere-like aggregates. Flow cytometric analysis of Tubulin-III and Tau positive cells revealed that the percentages of these cells were increased significantly for the two markers following DHEA treatment at both stages. Moreover, Western blot analysis revealed that Tubulin-III protein was strongly induced by DHEA. The expression of neuronal specific genes such as Isl-1, Tubulin III, Pax6 and Nestin was also detected by RT-PCR analysis as well as BrdU incorporation and found to have increased significantly after DHEA induction. In conclusion, these results provide evidence that DHEA can affect neuronal-competent MSCs in inducing the expression of a comprehensive set of genes and proteins that define neuronal cells. DHEA was also able to induce the division of neuronalcompetent MSCs, thereby increasing the number of cells with major neuronal characteristics. To our knowledge, this is the first report which shows that DHEA can induce the division and differentiation of MSCs into neurons in vitro and should provide an improved basis for new treatments using MSCs of a wide variety of neurological diseases.
Introduction
Dehydroepiandrosterone (DHEA), its sulfate ester (DHEAS) and other related steroids as well as allopregnanolone (Allo) represent the most abundant steroid products of the adrenal cortex. They are found to be synthesized de novo in brain glial cells and their concentrations are particularly high in the brain and are therefore considered to be neurosteroids (Kaasik et al., 2001 , Lapchak and Araujo, 2001 , Marx et al., 2000 . Moreover, DHEA levels have been found to decline in mental illnesses such as major depressive disorder or in systematic diseases that respond to DHEA supplementation (Bloch et al., 1999 , Roshan et al., 1999 . The decline of neurosteroid levels during aging may also leave the brain unprotected against neurotoxic challenges (Charalampopoulos et al., 2006b ). DHEA has further been shown to be neuroprotective after oxidative stress in rat hippocampal neuronal cultures (Bastianetto et al., 1999) and hippocampal damage induced by N-methyl-D-aspartate (NMDA) (Kimonides et al., 1998) or chromaffin cells and the sympathoadrenal PC12 cells (an established model for the study of neuronal cell apoptosis and survival) against serum deprivation-induced apoptosis (Charalampopoulos et al., 2006a) . Furthermore, it can directly stimulate biosynthesis and release of neuroprotective catecholamines, exerting a direct transcriptional effect on tyrosine hydroxylase and regulate actin depolymerization and submembrane actin filament disassembly, a fast-response cellular system regulating trafficking of catecholamine vesicles (Charalampopoulos et al., 2006b) . DHEA can also affect the endocrine, immune, and metabolic systems (Bellino et al., 1995) .
Recent studies have shown that mesenchymal stem cells (MSCs) derived from bone marrow cell suspensions can be expanded by their selective attachment to plastic tissue culture dishes (Friedenstein et al., 1976 , Reyes et al., 2001 , Sekiya et al., 2002 .
By far the most prominent advantage of using MSCs over other cell types in cell-replacement therapy is their autologous characteristic. In addition, these cells were reported to differentiate in vitro and in vivo into cells expressing neuronal and glial markers (Sanchez-Ramos et al., 2000 , Woodbury et al., 2000 , Zhao et al., 2002 . It has also been shown that like embryonic stem cells (ESCs), adult human MSCs in the presence of epidermal growth factor (EGF) and basic-fibroblast growth factor (bFGF) can become converted into a clonogenic neuronal stem cell-like population growing in neurosphere-like structures also called marrowderived neuronal stem cells (mNSC). These can then be differentiated into cells with morphological and functional characteristics of neuronal, and glial cells in vitro (Hermann et al., 2004) . Therefore MSCs provide an innovative model to understand developmental and molecular mechanisms of neurosteroid actions. Moreover, the use of MSCs in auto-graft protocols in neurological diseases necessitates the identification of the molecular events that are important for the induction of neuronal differentiation of MSCs. We have shown here that DHEA can induce the differentiation of neuronal cells from MSCs and increase their cell proliferation in vitro. These results have important implications for MSCs and are important in the understanding of DHEA actions on the process of neuronal differentiation from MSCs.
Results and Discussion

MSC characterization
MSCs were isolated from the femurs of adult mice and propagated in vitro as established previously in our laboratory (Eslaminejad et al., 2006) . At low plating densities, MSCs grew as a monolayer of large, flat cells and made colony forming unitfibroblast (CFU-F, Fig. 1A ). As the cells approached confluency, they assumed a more spindle-shaped and a fibroblastic morphology (Fig. 1B) . Flow cytometric analysis at the passages (4-6) demonstrated that the cells were negative for CD11b (Fig. 1C) , CD45 (Fig. 1D ), CD 34 (Fig. 1E ), Oct-4 (Fig. 1F) , cell surface markers associated with lymphohematopoietic cells and cell nuclear marker associated with multipotential adult progenitor cells (MAPCs). The MSCs did express CD44 (Fig. 1G ) and Sca-1 (Fig. 1H) , consistent with their undifferentiated state.
Neuronal Differentiation
To convert MSCs into cells with characteristics of NSCs, we detached the MSCs after 4-6 passages and cultured them in 1% agarose-coated dishes in serum-free neurobasal medium supplemented with bFGF+EGF. The cells did not adhere to the surface of culture dishes and formed small spheres of floating cells (Fig.  2 A,B ) and finally made mNSCs in vitro. Immunocytochemistry showed that mNSCs in the presence of only bFGF+EGF expressed high levels of Nestin (Fig. 2C) . The flow cytometric analysis showed that Nestin expression in MSCs increased from 27.5±2.1 to 77.5±0.6 (P<0.001, Fig. 2D ) in day 7 and decreased in day 11 to 62.5±1.5 (P<0.001, Fig. 2D ). Therefore in order to confirm the differentiation potential of these cells, neurosphereslike aggregates were dissociated and plated to poly-L-lysine coated plates for 12 days under differentiating conditions. We first asked what role DHEA may play in the neuronal differentiation of MSCs in culture. To establish whether DHEA could enhance the differentiation rate, we added different concentration of DHEA (0.1, 1.0 and 10 µM) with and without RA (1 µM) at the plating stage. Within 4 to 12 days after plating, changes in the morphology of responsive cells assuming neuronal identity became apparent. These morphological changes were similar to those reported previously (Hermann et al., 2004) , in which the cytoplasm in the flat cells was initially retracted towards the nucleus, forming a contracted multipolar cell body leaving membranous processes like peripheral extensions. Over the subsequent days, the cell bodies became increasingly spherical and retractile, exhibiting a typical neuronal perikaryal appearance. Gradually, MSCs-derived neurons displayed distinct neuronal morphologies ranging from simple bipolar to large, extensively branched multipolar cells (Fig. 2E) , making conncetions via their processes (Fig.  2F) . Some of the differentiated cells also acquired morphological and phenotypical characteristics of astrocytes ( Fig. 2G ). Following the fixation process, the cells were immunostained for the neuronal markers; Tubulin-III ( Fig. 2H ) and Tau ( Fig. 2I ), as well as the astrocyte marker; GFAP (Fig. 2J ). The results further verified the presence of many well differentiated neurons and astrocytes. Moreover, the expression of neuronal specific genes such as Isl-1, Tubulin III, Pax6, and Nestin were also studied by RT-PCR analysis ( Fig. 2K ) in which they were found to be weakly expressed in MSCs. Westren blot analysis using anti-Tubulin III antibody revealed that Tubulin-III protein was only induced strongly following the DHEA addition (Fig. 2L ). The expression of neuronal markers in mouse bone marrow-derived MSCs has been reported in the past where the MSCs were found to express certain neuronal phenotype markers spontaneously in the absence of specialized induction reagents in culture. These cells were believed to be probably «primed» toward a neuronal fate by the constitutive expression of neuronal antigens and seemed to 
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A respond with an appropriate neuronal pattern of differentiation, when exposed to the environment of the developing brain (Deng et al., 2006) . The analysis of Tubulin-III positive cells by flow cytometry revealed that the percentage of these cells was increased significantly following DHEA or RA treatment (at least P<0.01, Fig. 2M ) and that there was no significant differences between different concentrations of DHEA (0.1, 1.0 and 10 µM). We therefore continued our experiments with 1 µM DHEA but found that only the highest concentration of DHEA (10 µM) when used with RA treatment improved the neuronal differentiation and not the DHEA (0.1 or 1 µM) or RA alone (Fig. 2M) .
To assess the DHEA influence in the stage of neurosphereslike aggregate formation and the effect of bFGF+EGF, DHEA was added in either the presence or absence of bFGF+EGF in culture. Flow cytometric analysis of Tubulin-III and Tau positive cells after plating, revealed that the percentage of these cells was increased significantly for the two markers following DHEA treatment at both the neurosphere-like aggregate formation stage (protocol 2 and 3) and plating stage (protocol 1) (at least P<0.01, Fig. 3 ). The percentage increase in these markers following DHEA treatment and bFGF+EGF however, was not found to be significant. Moreover, Western blot analysis revealed that Tubulin-III protein was strongly induced by only DHEA in the neurosphere-like aggregate formation stage with or without bFGF+EGF in comparison with addition of DHEA in the plating stage (Fig. 2L ).
DHEA has also been shown to be a potential signaling molecule in neuronal differentiation during development (Compagnone and Mellon, 1998) and has recently been shown to increase neurogenesis in the adult rodent hippocampus (Karishma and Herbert, 2002) . DHEA is also found to be involved in the maintenance and division of human NSC cultures derived from the fetal cortex (Suzuki et al., 2004) . Moreover, it is reported that DHEA enhances the differentiating effect of RA on neuroblastoma cells via a signalling pathway that is not RA receptor-mediated (Silvagno et al., 2002) .
To evaluate the possible mechanism of DHEA function, it was administrated in the neurosphere-like aggregate formation stage with and without bFGF+EGF (protocol 3 and 2, respectively). The diameter of neurosphere-like aggregates was found to increase significantly when DHEA used at this stage (P<0.001) in either the presence or absence of bFGF+EGF (Fig. 4A) . To evaluate this enhancement, BrdU incorporation assay were performed with mNSCs after DHEA induction at day 7 in the presence or absence of bFGF+EGF (Fig. 4B1, 4B2 72.4±3.3% of mNSCs without bFGF+EGF and in the presence of DHEA (protocol 3) were positive for BrdU staining, (P<0.001 vs other groups, Fig. 4E ). Therefore the BrdU incorporation has increased significantly in the presence of bFGF+EGF by DHEA and these data also show that DHEA has selectively increased the division of the cells responsive to bFGF+EGF within the neurosphere-like aggregates.
In general neurosteroids possess the ability to effect neurons through activation of γ-aminobutyric acid (GABA), NMDA, and sigma receptors (Baulieu, 1997 , Baulieu, 1998 , Suzuki et al., 2004 , Xilouri et al., 2007 , Xilouri and Papazafiri, 2006 , however the exact role of each factor with regard to DHEA is not well established. Moreover, the prosurvival effect of DHEA appears to be mediated by G-protein-coupled-specific membrane binding sites (Charalampopoulos et al., 2006a) . This involves the antiapoptotic Bcl-2 proteins, the activation of prosurvival transcription factors; CREB and NF-kappaB and the expression of upstream effectors of the antiapoptotic Bcl-2 protein, as well as a posttranslational activator of Bcl-2; the prosurvival kinase PKCalpha/beta, (Charalampopoulos et al., 2006b ). The neuroprotection also involves phosphorylation of the prosurvival factor Src and the induction of the anti-apoptotic protein Bcl-2 (Charalampopoulos et al., 2006a) . DHEA is found to inhibit excitotoxic cell death of P19-N neurons, by directly maintaining the activation of PKB/Akt kinase and interfering with the intrinsic mitochondrial apoptotic pathway, preserving cytochrome C in the mitochondria and Bax in the cytoplasm (Xilouri et al., 2007) .
Taken together, these results have shown that DHEA can induce the expression of a comprehensive set of genes and proteins that define neuronal cell identity in neuronal-competent MSCs forming mNSCs. Moreover, our results suggest that DHEA can induce the division of mNSCs and so increase the number of cells with major neuronal-like characteristics. To our knowledge, this is the first report that DHEA has been shown to induce the division and differentiation of MSCs into neuron-like cells in vitro, when added at either the neurosphere-like aggregate formation stage and/or the plating stage. MSCs may therefore be useful in the treatment of a wide variety of neurological diseases, offering significant advantages over other "stem" cells. The marrow cells are readily accessible, overcoming the risks of obtaining either NSCs from the brain or ESCs from preimplantation embryos while also provide a renewable population of cells.
Materials and Methods
Culture and expansion of MSCs
Mouse MSCs were cultured in Dulbecco modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 1% penicillin/ streptomycin, and 2 mM L-glutamine. They were grown to confluency before being detached by Trypsin/EDTA treatment and were seeded at 1◊10 4 cell/cm 2 in culture flasks before being evaluated for their multipotency while differentiating into chondrocytes, adipocytes, and osteoblasts (Eslaminejad et al., 2006) . All aforementioned materials were purchased from Invitrogen-Gibco.
Neuronal Induction
MSCs were dissociated with 0.05% trypsin/0.04% EDTA and cultured on agarose (Sigma-Aldrich)-coated dishes (60 mm, Nunc) at a concentration of 1x10 5 cells/ml in neurobasal medium containing B27 (2%, Invitrogen-Gibco), 1% insulin-transferrin-selenite (ITS, Invitrogen-Gibco), Lglutamine, 1% penicillin/streptomycin supplemented with 20 ng/ml of both EGF and bFGF (both from Sigma-Aldrich) at 5% CO2.
Induction of terminal neuronal differentiation was initiated by plating the cells on poly-L-lysine-(Sigma-Aldrich) coated plates at a concentration of 3 x 10 4 cells/cm 2 in the same medium without bFGF+EGF and in presence of 10% FCS and 1 µM all-trans-retinoic acid (RA, SigmaAldrich). Cells were differentiated for 12 day and the medium was changed every four days. DHEA was added in plating stage (protocol 1) or in neurospheres-like stage in presence (protocol 2) and/or absence (protocol 3) of bFGF+EGF (Table 1) .
Immunofluorescence staining
Cultured cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) and rinsed with PBS (Invitrogen-Gibco)-Tween20 (Sigma-Aldrich). The cells were permeabilized by 0.5% Triton X-100 and blocked with 10% normal serum produced from the same species as the secondary antibody. This was followed by an overnight incubation with primary antibodies including anti-Nestin (Chemicon, MAB353, 1:100), anti-β-Tubulin-III (Sigma-Aldrich, T5293, 1:200), anti-Tau (Millipore, MAB5270, 1:400), anti-BrdU (Roche, 11296736001, 1:200) , and anti-glial fibrillary acidic protein (GFAP, Chemicon, MAB3402, 1:400). After rinsing, samples were incubated with secondary antibody: fluorescein isothiocyanate (FITC)-conjugated anti-mouse (Chemicon, AP308, 1:250) and the cells which were labeled with FITC were counterstained with 4,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, D-8417, 0.02 µg/ml) and/or 1 µg/ml propidium iodide (PI, Sigma-Aldrich, P4864) for 3 min at room temperature. Omission of the primary antibody in the sample was used as a control for all markers. Labeled cells were examined with a fluorescence microscope (Olympus, BX51, Japan) and images were acquired with an Olympus D70 camera.
Flow cytometric analysis
All staining reactions were performed in staining buffer consisting of PBS supplemented with 2% FCS. After determination of the viability of the cells by trypan blue exclusion, cells were washed two times in staining buffer and fixed in 4% paraformaldehyde and triton X-100 0.5% was used for permeabiliztion. Non-specific antibody binding was blocked with a combination of 10% heat-inactivated goat serum in staining buffer and 1-1.5 x 10 5 cells were used per sample. Cells were incubated with the appropriate primary antibodies or appropriate isotype matched controls (Dako, X0927, 1:100). Primary antibodies used here were: anti-Nestin (1:20), anti-β-Tubulin III (1:200), anti-Tau (1:400), and anti-BrdU (1:100). The cells were washed two times in staining buffer and incubated for 30 min at 4 °C with FITC-conjugated secondary antibody. After washing, flow cytometric analysis was performed with a BD-FACS Calibur Flow Cytometer. The experiments were replicated three times and the acquired data was analyzed by using the WinMDI (2.9) software.
RNA extraction and RT-PCR analysis
Total cellular RNA was extracted from the cells in different stages using total RNA (Nucleospin ® ) purification kit followed by treatment with RNase-free DNase (Qiagen, Hilden, Germany). Standard RT was performed using 2 µg total RNA, oligo (dT), and the RevertAid TM First Strand cDNA Synthesis Kit (Fermentas) according to the manufacturer's instructions. The cDNA samples were subjected to polymerase chain reaction (PCR) amplification using mouse specific primers. Amplification conditions were as follows: Initial denaturation at 94 °C for 5 min, 35 cycles of denaturation at 94 °C for 30 sec, annealing at 55-70 °C for 45 sec (see Table 2 for temperatures used) and extension at 72 °C for 45 sec, followed by a final extension at 72 °C for 10 min. The PCR products were analyzed by gel electrophoresis on a 1.7% agarose gel stained with ethidium bromide (1µg/ml) after which they were visualized and photographed on 
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gel documentation system (UVidoc, UK). A description of primers and the sizes of their final products are described in Table 2 .
Western blot Analysis
Twenty micrograms of protein extracted from the cells at different stages was separated by 10% SDS-PAGE electrophoresis using a Mini-PROTEAN 3 electrophoresis cell (Bio-Rad). Proteins were transferred to a nitrocellulose membrane (Bio-Rad) by semidry blotting (Bio-Rad) using Dunn carbonate transfer buffer (10 mM NaCHO3, 3 mM Na2CO3, and 20% methanol) and membranes were blocked for 1.5 h using Western blocker solution (Sigma-Aldrich, W0138) before being incubated with an antibody against β-Tubulin III (1:200) or anti-actin (Sigma-Aldrich, A5441, 1:5000). After washing, the membranes were incubated with the peroxidase-conjugated secondary antibody goat anti mouse horse reddish peroxidase (Sigma-Aldrich, A9044, 1:80).
Diameter of neurosphere-like aggregates
The diameter of neurosphere-like aggregates was measured under phase contrast inverted microscope (Olympus, Japan) using an Olysia Bioreport software in days 3 and 7.
Statistical analysis
The experiments were replicated at least three times. The data were expressed as mean ± SD (standard deviation). One-way ANOVA followed by the Tukey post hoc test multiple group comparison was used to analyze group differences of the data collected from flow cytometric analysis. The difference between groups was then considered to be statistically reliable if the value of P< 0.05 was obtained.
